These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11718612)

  • 1. Is hyperhomocysteinemia a risk factor or a consequence of coronary heart disease?
    Cattaneo M
    Arch Intern Med; 2001 Nov; 161(21):2628-9. PubMed ID: 11718612
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine and coronary artery disease.
    Cheng TO
    Atherosclerosis; 1999 Aug; 145(2):419. PubMed ID: 10488972
    [No Abstract]   [Full Text] [Related]  

  • 3. The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease.
    Dierkes J; Bissé E; Nauck M; Orth M; Mayer H; Luley C; Wieland H
    Clin Chem Lab Med; 1998 Jun; 36(7):453-7. PubMed ID: 9746269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative view of homocysteine.
    Dudman NP
    Lancet; 1999 Dec; 354(9195):2072-4. PubMed ID: 10636386
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperhomocysteinemia and transplant coronary artery disease.
    Caldera A; Dec GW
    Transplantation; 2002 Nov; 74(10):1359-64. PubMed ID: 12451231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Homocysteine as a coronary risk factor].
    Derbeneva SA; Pogozheva AV
    Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of hyperhomocysteinemia as a cardiovascular risk factor in the prediction of coronary heart disease.
    Geisel J; Hennen B; Hübner U; Knapp JP; Herrmann W
    Clin Chem Lab Med; 2003 Nov; 41(11):1513-7. PubMed ID: 14656034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and cardiovascular risk: the perils of reductionism in a complex system.
    Ueland PM; Loscalzo J
    Clin Chem; 2012 Dec; 58(12):1623-5. PubMed ID: 22623744
    [No Abstract]   [Full Text] [Related]  

  • 9. Reducing coronary artery disease by decreasing homocysteine levels.
    Coffey M; Crowder GK; Cheek DJ
    Crit Care Nurse; 2003 Feb; 23(1):25-30. PubMed ID: 12640957
    [No Abstract]   [Full Text] [Related]  

  • 10. [The mechanisms of hyperhomocysteinemia in coronary heart disease].
    Gao W; Jiang N; Zhu G
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):821-3. PubMed ID: 11038775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine--an atherogenic and a thrombogenic factor?
    Ubbink JB
    Nutr Rev; 1995 Nov; 53(11):323-5. PubMed ID: 8643214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.
    Bostom AG; Gohh RY; Liaugaudas G; Beaulieu AJ; Han H; Jacques PF; Dworkin L; Rosenberg IH; Selhub J
    Atherosclerosis; 1999 Jul; 145(1):221-4. PubMed ID: 10428313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine: the latest risk factor for heart disease.
    Reeder SJ; Hoffmann RL; Magdic KS; Rodgers JM
    Dimens Crit Care Nurs; 2000; 19(1):22-8. PubMed ID: 10876482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels.
    Ali A; Mehra MR; Lavie CJ; Malik FS; Murgo JP; Lohmann TP; Li S; Lin HC; Milani RV
    Am J Cardiol; 1998 Dec; 82(12):1543-5, A8. PubMed ID: 9874065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine levels in cardiovascular disease, malaria and protein-energy malnutrition in Sudan.
    Abdel GA; Abdullah SH; Kordofani AY
    East Mediterr Health J; 2009; 15(6):1432-9. PubMed ID: 20218135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of mild hyperhomocysteinemia with cardiac graft vascular disease.
    Ambrosi P; Garçon D; Riberi A; Habib G; Barlatier A; Kreitmann B; Rolland PH; Bouvenot G; Luccioni R; Métras D
    Atherosclerosis; 1998 Jun; 138(2):347-50. PubMed ID: 9690918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of homocysteinemia and MTHFR 677CT polymorphism with Framingham Coronary Heart Risk Score.
    Gariglio L; Riviere S; Morales A; Porcile R; Potenzoni M; Fridman O
    Arch Cardiol Mex; 2014; 84(2):71-8. PubMed ID: 24793554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine level and coronary artery disease.
    Kazemi MB; Eshraghian K; Omrani GR; Lankarani KB; Hosseini E
    Angiology; 2006; 57(1):9-14. PubMed ID: 16444451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia as a consequence of life style among patients suffering from thromboangiitis obliterans.
    Fazeli B; Ravari H
    Int Angiol; 2013 Aug; 32(4):442-3. PubMed ID: 23822948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.